•
Sep 30, 2024

Lexicon Pharmaceuticals Q3 2024 Earnings Report

Total Revenue
$1.75M
Previous year: $162K
+980.2%
EPS
-$0.18
Previous year: -$0.21
-14.3%
Gross Profit
$1.55M
Previous year: $4K
+38725.0%
Cash and Equivalents
$258M
Previous year: $218M
+18.3%
Free Cash Flow
-$53.9M
Previous year: -$41.7M
+29.3%
Total Assets
$321M
Previous year: $276M
+16.1%

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals